Teva Pharmaceutical Industries Limited (TEVA) Short Interest
NYSE • TEVA • IL0006290147
As of Nov 3, 2026, ORTEX estimates 2.6% of free float is sold short, 4.3 days to cover, cost to borrow 0.53%.
NYSE • TEVA • IL0006290147
As of Nov 3, 2026, ORTEX estimates 2.6% of free float is sold short, 4.3 days to cover, cost to borrow 0.53%.
This page tracks how heavily Teva Pharmaceutical Industries Limited (NYSE:TEVA) is being shorted: ORTEX's daily short interest estimate, the cost to borrow the shares, utilization of the lendable supply and days to cover, next to the official exchange-reported figure.
Source: ORTEX. Some figures are limited on the free view; live data and full history are part of ORTEX Advanced.
Teva Pharmaceutical Industries Limited (NYSE: TEVA) has a market capitalization of $48.84B. Last close $41.91 (as of 2026-11-04); 52-week range $26.00 to $43.34. ORTEX data as of 2026-11-03: short interest is 2.57% of free float, 4.3 days to cover and the average cost to borrow is 0.53%.